The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy-Reference-Cited by-同舟云学术

The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy

Published:2018-07-30 Issue:8 Volume:38 Page:4877-4882
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

AOYAMA TORU,YAMAMOTO NAOTO,KAMIYA MARIKO,MURAKAWA MASAAKI,TAMAGAWA HIROSHI,SAWAZAKI SHO,NUMATA MASAKATSU,SHIOZAWA MANABU,KOBAYASHI SATOSHI,UENO MAKOTO,MORIMOTO MANABU,YUKAWA NORIO,OSHIMA TAKASHI,YOSHIKAWA TAKAKI,RINO YASUSHI,MASUDA MUNETAKA,MORINAGA SOICHIRO

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VPAC2 receptor signaling promotes pancreatic cancer cell growth and decreases the immunogenicity of the tumor microenvironment;2024-01-17

2. Cancer immunotherapy responses persist after lymph node resection;2023-09-22

3. Total Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinoma Is Associated With Limited Lymph Node Yield but Improved Ratio;Journal of Surgical Research;2022-12

4. Lymph node ratio predicts recurrence-free survival and disease-specific survival of patients with pyriform sinus squamous cell carcinoma;Asian Journal of Surgery;2022-09

5. Prediction scores of postoperative liver metastasis and long‐term survival of pancreatic head cancer based on the distance between the mesenteric vessels and tumor, preoperative serum carbohydrate antigen 19‐9 level, and lymph node metastasis rate;Cancer Medicine;2022-07-13